The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of favezelimab in combination with pembrolizumab for heavily pretreated anti–PD-1–refractory classical Hodgkin lymphoma (cHL): An updated analysis.
 
John Timmerman
Honoraria - Kite/Gilead
Consulting or Advisory Role - DAVA Oncology; Kite/Gilead; Oncovalent Therapeutics; Oncovalent Therapeutics
Research Funding - Bristol-Myers Squibb; Kite, a Gilead company; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David Lavie
Consulting or Advisory Role - Abbvie; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie
 
Nathalie A. Johnson
Honoraria - Merck; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Merck; Roche
 
Abraham Avigdor
Consulting or Advisory Role - Abbvie; BMSi; Gilead Sciences; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Borchmann Peter
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Takeda
Research Funding - Amgen; Merck Sharp & Dohme; MPI Research; Novartis; Roche; Takeda
 
Charalambos Andreadis
Consulting or Advisory Role - Atara Biotherapeutics; BMS; Epizyme; Gilead Sciences; Incyte; Karyopharm Therapeutics; Kite, a Gilead company
Research Funding - BMS; Genmab; Merck; Novartis; Roche/Genentech
 
Ali Bazargan
No Relationships to Disclose
 
Gareth P. Gregory
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Clinigen Group; Gilead Sciences; Janssen; MSD; Roche/Genentech; Sandoz-Novartis
Speakers' Bureau - Abbvie; Roche/Genentech
Research Funding - BeiGene; Janssen; Merck
Expert Testimony - Janssen
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Novartis; Roche/Genentech
 
Colm Keane
Consulting or Advisory Role - BeiGene; Janssen; Karyopharm Therapeutics; Roche
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - Bristol-Myers Squibb; MSD
Other Relationship - Gilead Sciences; MSD; Roche
 
Inna Torzan
No Relationships to Disclose
 
Vladan Vucinic
Honoraria - Amgen; BMS GmbH & Co. KG; Gilead Sciences; Janssen
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Janssen; Sobi
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis
 
Rachel Marceau West
Employment - Merck
 
Pallavi Pillai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Patricia Marinello
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; Alimera Sciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)